Neo New Oncology

Neo New Oncology — the German company founded in 2012 dealing with issues of diagnosis of oncological diseases. The main efforts of Neo New Oncology are directed to determination of traces of a genome of cancer in blood. As of May, 2016 in the company 30 employees work.

2016: Sale of Siemens Healthineers

On May 17, 2016 the Siemens Healthineers company announced purchase of Neo New Oncology. The transaction was closed in March, 2016, its cost does not reveal.

Acquisition of Neo New Oncology as reported in Siemens Healthineers, will provide the last "point of entry" in new generation of technologies of genomic testing by means of a skvenirovaniye and also will expand possibilities of the accompanying diagnostics of Siemens Healthineers and will increase the accuracy of physical examinations.

Purchased Siemens Healthineers the developer of services of diagnosis of cancer Neo New Oncology

We are concentrated on expansion of business in three following areas: molecular diagnostics, services and advanced therapy — David Stein, the head of department of strategy and innovations of Siemens Healthineers says. — Neo New Oncology integrates these three areas, providing services on the basis of molecular diagnostics and the products having the diagnostic potential and also therapeutic solutions in oncology. This acquisition allows us to come to the undeveloped area thanks to ultramodern offers.

The CEO of Neo New Oncology Andreas Jenne noted that under Siemens Healthineers wing the company will be engaged in development of new complete solutions for diagnosis of oncological diseases and also expansion of a portfolio of services and offers which will help doctors to select the correct methods of treatment of patients.^[1]

Notes